je.st
news
Tag: asco
Studies Presented at 2015 ASCO Meeting Demonstrate Predictive Power...
2015-05-30 15:37:39| Logistics - Topix.net
The meeting runs May 29-June 2, 2015, in Chicago. In the first prospective trial investigating the impact of BCI in clinical practice, BCI results led to changes in treatment decisions in 27 percent of patients tested, and significantly reduced patient anxiety regarding decisions about whether to extend endocrine therapy to 10 years.
Tags: power
presented
studies
meeting
First Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with Mercks KEYTRUDA (pembrolizumab) Presented at 2015 ASCO Annual Meeting and Published in the New England Journal of Medicine
2015-05-29 20:05:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Early Findings Show DNA Mismatch Repair-Deficient Colorectal and Other Tumors Highly Responsive to Checkpoint Blockade with Anti-PD-1 Therapy Merck Plans to Initiate Phase 2 Registrational Study with KEYTRUDA (KEYNOTE-164) to Evaluate MMR-Deficiency in Colorectal Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from the first study evaluating the correlation of benefit with an immunotherapy based on DNA mismatch repair (MMR) deficiency, a well-established form of genetic instability in many cancers characterized by the loss of function of the MMR pathway. Language: English Contact: MerckMedia:Pamela Eisele, 267-664-0282Claire Mulhearn, 908-200-1889orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Cavion to Present Clinical Trial Data at ASCO
2015-05-29 02:53:23| Logistics - Topix.net
Cavion LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors and neurologic diseases, announced today that Matthias Holdhoff, MD, PhD of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins will present preliminary results from an ongoing multi-site National Cancer Institute Adult Brain Tumor Consortium and Cavion-sponsored Phase 1b clinical trial at the 2015 Annual Meeting of the American Society of Clinical Oncology on June 1. This dose escalation trial, which completed enrollment in November 2014, evaluates the safety and pharmacokinetics of Cavion's novel cancer drug mibefradil when sequentially administered with temozolomide in patients with recurrent high-grade glioma.
Tags: data
present
trial
clinical
ASCO Immunotherapy Preview: These Cancer-Killing Viruses May Save Lives
2015-05-28 16:50:49| Logistics - Topix.net
I am a science journalist and author who specializes in covering healthcare, pharmaceuticals and biotechnology. I am the author of Heal: The Vital Role of Dogs in the Search for Cancer Cures and Selling the Fountain of Youth .
Tags: save
lives
preview
viruses
ASCO Wins 2015 Grand Prize
2015-05-28 12:31:07| Industrial Newsroom - All News for Today
A sinter-hardened steel planetary gear system, featuring a carrier with an integrated sun gear and three planetary gears, earned the Grand Prize in the Medical/Dental Category for ASCO Sintering Co., Commerce, California, USA. The system is used in multiple stacks for gear reduction in a single-use, portable...
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »